La Pristine Bioceuticals Private Limited

La Pristine Bioceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U74140DL2011PTC357712 Incorporated 08 April 2011 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2024
₹60.46 Cr
▲ 17% YoY
Net profit · FY 2024
₹3.76 Cr
Net margin 6.2%
EBITDA · FY 2024
₹6.54 Cr
EBITDA margin 10.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹42 Lakh
Secured borrowings
Company age
15 yrs
Est. 2011
Employees · EPFO
203
Provident fund records

About La Pristine Bioceuticals Private Limited

Data last updated:

La Pristine Bioceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 April 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74140DL2011PTC357712. Its GSTIN is 07AACCL0009K1ZT (Delhi). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Piyush Mansukhlal Shah and Girja Aima.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4232/1 Ansari Road Bhargava Street 1 Daryaganj, New Delhi, Delhi, India – 110002.

As per the financials filed for FY 2024, the company reported a revenue of ₹60.46 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹3.76 Cr (net margin 6.2%) and EBITDA of ₹6.54 Cr (EBITDA margin 10.8%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 12% over five years.

The company has about 203 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹42 Lakh on record. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it; 1 case is pending. The company has 6 deals on record (5 secondary share transfers, 1 rights issue); the latest was in March 2023. Its 10 peer companies in the Pharma industry (Pharma Retail and Distribution) are compared by revenue, 5 larger and 5 smaller; the largest is Agrowers Private Limited with revenue of ₹62.06 Cr. The company has 9 MSME Form 1 returns on record between 2019 and 2023, listing 171 overdue payments to 13 micro and small suppliers.

La Pristine Bioceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0030408). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lapristine.in.

Company Details of La Pristine Bioceuticals Private Limited
CIN U74140DL2011PTC357712
Registration Number 357712
Incorporation Date 08 April 2011
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-UP-28-0030408

CIN History of La Pristine Bioceuticals Private Limited

La Pristine Bioceuticals has one previous CIN (Corporate Identification Number): U74140HR2011PTC042644. The current CIN is U74140DL2011PTC357712, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U74140DL2011PTC357712Current
U74140HR2011PTC042644Previous

Recognitions & Rankings of La Pristine Bioceuticals

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-UP-28-0030408
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    4232/1 Ansari Road Bhargava Street 1 Daryaganj, New Delhi, Delhi, India – 110002
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
La Pristine Bioceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full La Pristine Bioceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for La Pristine Bioceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of La Pristine Bioceuticals Private Limited

The main business activity of La Pristine Bioceuticals is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of La Pristine Bioceuticals Private Limited FY 2025 filings available

La Pristine Bioceuticals Private Limited reported revenue of ₹60.46 Cr (up 17% YoY) for FY 2024.

Revenue · FY 2024
₹60.46 Cr ▲ 17%
Net profit · FY 2024
₹3.76 Cr margin 6.2%
EBITDA · FY 2024
₹6.54 Cr margin 10.8%

Compounded Annual Growth Rate (CAGR) of La Pristine Bioceuticals Private Limited

Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 28%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 87%
5 years · compounded
▲ 32%

Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 17% growth in the latest year. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of La Pristine Bioceuticals Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹6.54 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹3.76 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of La Pristine Bioceuticals Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin10.8%••••••••••••••••
Net Profit Margin6.2%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of La Pristine Bioceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of La Pristine Bioceuticals Private Limited

La Pristine Bioceuticals has 8 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Piyush Mansukhlal ShahDirector11 Jun 201511 Years 4 MonthsCurrent
Girja AimaDirector11 Jun 201511 Years 4 MonthsCurrent
Shairul Shishir ParikhDirector30 Mar 201511 Years 6 MonthsCurrent
Mir AmanullahDirector30 Mar 201511 Years 6 MonthsCurrent
Khairoon RathoreDirector01 Apr 20197 Years 6 MonthsCurrent
Pravinchandra Bhikhabhai DesaiDirector11 Jun 201511 Years 4 MonthsCurrent
Showing 6 of 8 current directors. View all directors

Peer Comparison of La Pristine Bioceuticals Private Limited

La Pristine Bioceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Agrowers Private Limited₹62.06 Cr (FY 2025)••••••••••••Kolkata, West Bengal, India
Kurnool Institute of Oncology Private Limited₹61.84 Cr (FY 2025)••••••••-10.0%••••Kurnool, Andhra Pradesh, India
Marc India Limited₹61.81 Cr (FY 2024)••••••••1.0%••••New Delhi, Delhi, India
Farmacross India Private Limited₹60.97 Cr (FY 2025)••••••••11.0%••••Mumbai, Maharashtra, India
Fourtrek Healthcare Private Limited₹60.77 Cr (FY 2025)••••••••3.0%••••Ahmedabad, Gujarat, India
La Pristine Bioceuticals Private Limited this company₹60.46 Cr (FY 2024)••••••••17.0%••••New Delhi, Delhi, India
Zil Pharma Enterprises Private Limited₹60.12 Cr (FY 2025)••••••••44.0%••••Mumbai, Maharashtra, India
Medishri Healthcare Private Limited₹59.87 Cr (FY 2025)••••••••17.0%••••New Delhi, Delhi, India
Myjoy Pharmaceuticals Private Limited₹59.43 Cr (FY 2025)••••••••-81.0%••••Kolkata, West Bengal, India
Bishak Pharma Private Limited₹58.84 Cr (FY 2025)••••••••31.0%••••Hyderabad, Telangana, India
Srinivasa Pharma Distributors Private Limited₹58.45 Cr (FY 2025)••••••••-10.0%••••Guntur, Andhra Pradesh, India

Peers are the five companies nearest above and the five nearest below La Pristine Bioceuticals by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of La Pristine Bioceuticals Private Limited

La Pristine Bioceuticals Private Limited is audited by PREKSHIT MEHTA & ASSOCIATES for the financial year 2022.

NameStatusAppointment DateCessation Date
PREKSHIT MEHTA & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of La Pristine Bioceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of La Pristine Bioceuticals Private Limited

Open charges
₹42 Lakh
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹0.42 Cr
Latest charge details
DateLenderAmountStatus
08 Apr 2023Hdfc Bank Limited₹25 LakhOpen
02 Jun 2022Hdfc Bank Limited₹17 LakhOpen

Total charge records: 2 View all charges

Deals & Funding of La Pristine Bioceuticals Private Limited

La Pristine Bioceuticals Private Limited has 6 deals on record (5 secondary share transfers, 1 rights issue); the latest was in March 2023.

Total deals
6
Secondary share transfers
5
Rights issue
1

Deals on record (5 of 6)

WhenDealAmountParties
Mar 2023Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Jan 2021Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Dec 2020Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Apr 2019Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2019Secondary share transferUndisclosedBuyer: an individual
Seller: 4 individuals
Premium access

Full deal history

All 6 deals with amounts, valuations, instruments and every party are in the company report.

  • Every funding round and share transfer
  • Amounts and valuations
  • Investors, buyers and sellers
  • Instruments and deal dates

Verified entity values are shown only after access is granted.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME Payment Delays by La Pristine Bioceuticals Private Limited

La Pristine Bioceuticals Private Limited has 9 MSME Form 1 returns on record between 2019 and 2023, listing 171 overdue payments to 13 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 13)

SupplierAmount dueDue sinceReported on
Sunbeam Lifesciences Private Limited••••••••••••
Pharma Synth Formulations Limited••••••••••••
Logos Pharma••••••••••••
Hi-Tech Formulations Private Limited••••••••••••
Samrvir Biotech Private Limited••••••••••••
Premium access

Full MSME payment history

Every supplier, amount and due date from all 9 MSME Form 1 returns is in the company report.

  • Every reported supplier due
  • Amounts and due dates
  • Reasons given in each return
  • Period-by-period history

Verified entity values are shown only after access is granted.

Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.

Employees and EPFO Compliance at La Pristine Bioceuticals Private Limited

La Pristine Bioceuticals Private Limited has a workforce of 203 employees as of Mar 31, 2024.

Employee count
203
Active EPFO establishments
1
Employee growth
6.84%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on La Pristine Bioceuticals Private Limited

La Pristine Bioceuticals Private Limited has 17 board changes on record since 2011: 8 appointments and 9 cessations. The latest: Mahesh Mansukhlal Shah ceased to be Director on 04 Jun 2020.

AGM
La Pristine Bioceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
La Pristine Bioceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 25.00 Lakh with Charge ID 100728789 was registered on 08 Apr 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 17.00 Lakh with Charge ID 100602455 was registered on 02 Jun 2022.
Ceased
Mahesh Mansukhlal Shah ceased to be Director.
Ceased
Khairoon Rathore ceased to be Additional Director.
Appointed
Khairoon Rathore was appointed as Director.
Ceased
Pankul Rathore ceased to be Director.
Ceased
Girja Aima ceased to be Additional Director.
Ceased
Malvika Kalra ceased to be Additional Director.
Ceased
Mir Amanullah ceased to be Additional Director.
Ceased
Piyush Mansukhlal Shah ceased to be Additional Director.

10 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for La Pristine Bioceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of La Pristine Bioceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of La Pristine Bioceuticals Private Limited

La Pristine Bioceuticals has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
07AACCL0009K1ZTDelhiActive01 Jul 2017
09AACCL0009K1ZPUttar PradeshActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of La Pristine Bioceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about La Pristine Bioceuticals Private Limited

La Pristine Bioceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 April 2011 (15+ years old) and is registered under CIN U74140DL2011PTC357712.

La Pristine Bioceuticals reported revenue of ₹60.46 Cr for FY 2024 (up 17% YoY).

La Pristine Bioceuticals has 8 current directors:

La Pristine Bioceuticals reported a net profit of ₹3.76 Cr (net margin 6.2%) and EBITDA of ₹6.54 Cr (EBITDA margin 10.8%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of La Pristine Bioceuticals is 28% over three years and 12% over five years. In the latest year (FY 2024) revenue rose 17%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of La Pristine Bioceuticals is 07AACCL0009K1ZT, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AACCL0009K1ZP (Uttar Pradesh).

The CIN (Corporate Identification Number) of La Pristine Bioceuticals is U74140DL2011PTC357712. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

La Pristine Bioceuticals has 4 court cases on record: 3 filed by the company and 1 filed against it. 1 is pending. Most are in the high courts.

La Pristine Bioceuticals was incorporated on 08 April 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.

La Pristine Bioceuticals has 6 deals on record (5 secondary share transfers, 1 rights issue); the latest was in March 2023.

The peers of La Pristine Bioceuticals by revenue are Agrowers Private Limited, Kurnool Institute of Oncology Private Limited, Marc India Limited, Farmacross India Private Limited, Fourtrek Healthcare Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).

Mahesh Mansukhlal Shah ceased to be Director on 04 Jun 2020. Khairoon Rathore ceased to be Additional Director on 30 Sep 2019. Khairoon Rathore was appointed as Director on 01 Apr 2019. La Pristine Bioceuticals has 17 board changes on record in total.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available